ClinicalTrials.Veeva

Menu

Prospective Follow-up of Patients With Glycogen Storage Disease Type III (PRO GSDIII)

I

Institut de Myologie, France

Status

Unknown

Conditions

Neuromuscular Disorders

Treatments

Procedure: Different motor function tests
Procedure: Manual dexterity assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT01563705
2010-A00615-34

Details and patient eligibility

About

The aim of this study is to improve knowledge of natural history and methods of monitoring the evolution of Glycogen storage disease type III regarding the muscle and to study the prospective approach of large series of patients, and using the same protocol for the follow up of the children and adults.

Enrollment

30 estimated patients

Sex

All

Ages

10+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with a debranching enzyme deficiency confirmed by enzymatic analysis (debranching enzyme deficiency).
  • Written consent
  • Age: at least 10 years
  • Affiliated with a social security system

Exclusion criteria

  • Pregnant and lactating women

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Pascal Laforet, MD; Pierre Carlier, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems